Literature DB >> 10505120

Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium.

T Hudde1, S A Rayner, R M Comer, M Weber, J D Isaacs, H Waldmann, D F Larkin, A J George.   

Abstract

We investigated the efficiency of activated polyamidoamine dendrimers, a new class of nonviral vectors, to transfect rabbit and human corneas in ex vivo culture. In addition to assessing the expression of a marker gene we have demonstrated that this approach can be used to induce the production of TNF receptor fusion protein (TNFR-Ig), a protein with therapeutic potential. Whole thickness rabbit or human corneas were transfected ex vivo with complexes consisting of dendrimers and plasmids containing lacZ or TNFR-Ig genes. Following optimisation 6-10% of the corneal endothelial cells expressed the marker gene. Expression was restricted to the endothelium and was maximal after transfection with 18:1 (w/w) activated dendrimer:plasmid DNA ratio and culture for 3 days. The supernatant of corneas transfected with TNFR-Ig plasmid contained TNFR-Ig protein which was able to inhibit TNF-mediated cytotoxicity in a bioassay. We have therefore shown that activated dendrimers are an efficient nonviral vector capable of transducing corneal endothelial cells ex vivo. They may have applications in gene-based approaches aimed at prevention of corneal allograft rejection or in treatment of other disorders of corneal endothelium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10505120     DOI: 10.1038/sj.gt.3300886

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  20 in total

Review 1.  Gene therapy in the cornea: 2005--present.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Ashish Tandon
Journal:  Prog Retin Eye Res       Date:  2011-09-28       Impact factor: 21.198

Review 2.  Cellular magnetic resonance imaging: nanometer and micrometer size particles for noninvasive cell localization.

Authors:  Jonathan R Slotkin; Kevin S Cahill; Suzanne A Tharin; Erik M Shapiro
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

3.  Analysis of novel nonviral gene transfer systems for gene delivery to cells of the musculoskeletal system.

Authors:  Patrick Orth; Anja Weimer; Gunter Kaul; Dieter Kohn; Magali Cucchiarini; Henning Madry
Journal:  Mol Biotechnol       Date:  2007-10-17       Impact factor: 2.695

4.  Formation of plasmid-based transfection complexes with an acid-labile cationic lipid: characterization of in vitro and in vivo gene transfer.

Authors:  Jeremy A Boomer; David H Thompson; Sean M Sullivan
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

5.  High-level gene transfer to the cornea using electroporation.

Authors:  Kathleen Blair-Parks; Bonnie C Weston; David A Dean
Journal:  J Gene Med       Date:  2002 Jan-Feb       Impact factor: 4.565

6.  In vitro adenovirus mediated gene transfer to the human cornea.

Authors:  C F Jessup; H M Brereton; D J Coster; K A Williams
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

7.  Linear Polyethylenimine-DNA Nanoconstruct for Corneal Gene Delivery.

Authors:  Jason T Rodier; Ratnakar Tripathi; Michael K Fink; Ajay Sharma; Madhuri Korampally; Shubhra Gangopadhyay; Elizabeth A Giuliano; Prashant R Sinha; Rajiv R Mohan
Journal:  J Ocul Pharmacol Ther       Date:  2019 Jan/Feb       Impact factor: 2.671

8.  [Expression patterns of non-viral transfection with GFP in the organ of Corti in vitro and in vivo. Gene therapy of the inner ear with non-viral vectors].

Authors:  M Praetorius; S Pfannenstiel; C Klingmann; I Baumann; P K Plinkert; H Staecker
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

9.  Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactives.

Authors:  V Gajbhiye; P Vijayaraj Kumar; A Sharma; A Agarwal; A Asthana; N K Jain
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

10.  Comparison of non-viral methods to genetically modify and enrich populations of primary human corneal endothelial cells.

Authors:  Christoph Engler; Clare Kelliher; Karl J Wahlin; Caroline L Speck; Albert S Jun
Journal:  Mol Vis       Date:  2009-04-01       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.